Dr Jeffrey Manning, MD | |
900 Warren Ave Ste 401, East Providence, RI 02914-1430 | |
(401) 330-2480 | |
(401) 808-6329 |
Full Name | Dr Jeffrey Manning |
---|---|
Gender | Male |
Speciality | Sports Medicine |
Experience | 18 Years |
Location | 900 Warren Ave Ste 401, East Providence, Rhode Island |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932212081 | NPI | - | NPPES |
1932212081 | Medicaid | RI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207QS0010X | Family Medicine - Sports Medicine | MD13899 (Rhode Island) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Miriam Hospital | Providence, RI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Coastal Medical Physicians Inc | 0345658316 | 135 |
News Archive
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A new study showing the ability to apply a thin coating of viable respiratory epithelial cells to tissue engineered constructs using a commercially available spray device is especially promising for therapeutic approaches in development to repair or replace challenging structures such as trachea or bronchi.
Carefx Corporation, a leading provider of interoperable workflow solutions, and Imprivata®, Inc., the employee access management company, today announced that Johns Hopkins Health System, an internationally recognized group of healthcare institutions, has selected Carefx Fusionfx and Imprivata OneSign to deliver an integrated clinical access solution that streamlines access to workstations, applications and patient data. The complete, integrated system will launch in early 2010.
Speakers at the recent REG 2016 Summit highlighted the need for more research into the nature and effectiveness of treatment for COPD (Chronic Obstructive Pulmonary Disease) in a real-world environment.
An international team of scientists has successfully employed single molecule, real-time DNA sequencing technology from Pacific Biosciences of California, Inc. to provide valuable insights into the pathogenicity and evolutionary origins of the highly virulent bacterium responsible for the German E. coli outbreak.
› Verified 9 days ago
Entity Name | Coastal Medical Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780273540 PECOS PAC ID: 0345658316 Enrollment ID: O20210427001413 |
News Archive
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A new study showing the ability to apply a thin coating of viable respiratory epithelial cells to tissue engineered constructs using a commercially available spray device is especially promising for therapeutic approaches in development to repair or replace challenging structures such as trachea or bronchi.
Carefx Corporation, a leading provider of interoperable workflow solutions, and Imprivata®, Inc., the employee access management company, today announced that Johns Hopkins Health System, an internationally recognized group of healthcare institutions, has selected Carefx Fusionfx and Imprivata OneSign to deliver an integrated clinical access solution that streamlines access to workstations, applications and patient data. The complete, integrated system will launch in early 2010.
Speakers at the recent REG 2016 Summit highlighted the need for more research into the nature and effectiveness of treatment for COPD (Chronic Obstructive Pulmonary Disease) in a real-world environment.
An international team of scientists has successfully employed single molecule, real-time DNA sequencing technology from Pacific Biosciences of California, Inc. to provide valuable insights into the pathogenicity and evolutionary origins of the highly virulent bacterium responsible for the German E. coli outbreak.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey Manning, MD 10 Davol Sq Ste 400, Providence, RI 02903-4760 Ph: (401) 421-4000 | Dr Jeffrey Manning, MD 900 Warren Ave Ste 401, East Providence, RI 02914-1430 Ph: (401) 330-2480 |
News Archive
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A new study showing the ability to apply a thin coating of viable respiratory epithelial cells to tissue engineered constructs using a commercially available spray device is especially promising for therapeutic approaches in development to repair or replace challenging structures such as trachea or bronchi.
Carefx Corporation, a leading provider of interoperable workflow solutions, and Imprivata®, Inc., the employee access management company, today announced that Johns Hopkins Health System, an internationally recognized group of healthcare institutions, has selected Carefx Fusionfx and Imprivata OneSign to deliver an integrated clinical access solution that streamlines access to workstations, applications and patient data. The complete, integrated system will launch in early 2010.
Speakers at the recent REG 2016 Summit highlighted the need for more research into the nature and effectiveness of treatment for COPD (Chronic Obstructive Pulmonary Disease) in a real-world environment.
An international team of scientists has successfully employed single molecule, real-time DNA sequencing technology from Pacific Biosciences of California, Inc. to provide valuable insights into the pathogenicity and evolutionary origins of the highly virulent bacterium responsible for the German E. coli outbreak.
› Verified 9 days ago
Dr. Karen R. Smigel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Warren Ave Ste 400, East Providence, RI 02914 Phone: 401-331-1221 Fax: 401-751-8003 | |
Mr. Daniel T Shreve, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 47 Hazard Ave, Daniel T Shreve Md Inc, East Providence, RI 02914 Phone: 401-434-9100 Fax: 401-434-4732 | |
Dr. Margaret A Sun, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1445 Wampanoag Trail, Unite 205, East Providence, RI 02915 Phone: 401-434-0770 Fax: 401-633-6094 | |
Dr. Joyce A Alves, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1445 Wampanoag Trl, Ste 205, East Providence, RI 02915 Phone: 401-434-0770 Fax: 401-633-6094 | |
Dr. Manoj Kumar Garg, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Warren Ave, Ste 100, East Providence, RI 02914 Phone: 401-383-9662 Fax: 401-383-6526 | |
Jared Astrow, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 900 Warren Ave Ste 401, East Providence, RI 02914 Phone: 401-330-2488 Fax: 401-330-2483 | |
Anthony V. Rocha, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 387 Waterman Ave, East Providence, RI 02914 Phone: 401-438-2780 Fax: 401-438-4763 |